Generics

Compendium, compendia, compendial: Clearing up the mystery of these terms

In conversations about the role of quality standards in public health, you might come across the words “compendia” and “compendial.” At USP, terms like “compendial approaches,” “compendial standards,” and “compendial tools” are part of our everyday vocabulary. But their meaning can be a bit of a mystery to people who work outside of the pharmaceutical industry and regulatory bodies.

Share

Generic drugs: New approaches to maximize competition, lower prices and increase access

Generic drugs

Building the marketplace for generic medicines is a key strategy to containing drug costs in the US, one that USP actively supports through our standards-setting work.

Tags: Generics
Share

USP and Synthetic Therapeutic Peptides

USP and SyntheticTherapeutic Peptides

Anita Szajek, Ph.D., principal scientific liaison to USP’s Expert Panel on Therapeutic Peptides, examines therapeutic peptides, the transition from recombinant to synthetic manufacturing routes, and regulatory and quality-related questions.

Share

Pages